Cargando…
EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma
The enhancer of zeste homolog 2 (EZH2) plays a critical role in different components of anti-tumor immunity. However, the specific role of EZH2 in modulating MHC Class I antigen presentation and T cell infiltration have not been investigated in HCC. This study analyzed the expression and clinical si...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660515/ https://www.ncbi.nlm.nih.gov/pubmed/33180829 http://dx.doi.org/10.1371/journal.pone.0242191 |